Sevoflurane induces increased methylation of the presynaptic marker synaptophysin at the mRNA level and enrichment by m6A (Zhang et al., 2021), which decreases the expression of synaptophysin and leads to fine motor and cognitive impairment in young mice (Zhang et al., 2021). The gene discussed is SYP; the disease is Cognitive impairment.